A new study published in the journal ACS Medicinal Chemistry Letters has found that activation of the cannabinoid receptors – something done naturally by cannabis – can protect against colitis, which is an inflammatory reaction in the colon that is often autoimmune or infectious.
According to the study; “The CB2 cannabinoid receptor has been implicated in the regulation of intestinal inflammation”. With this in mind, researchers “developed constrained analogues” that were specifically designed to target the body’s cannabinoid receptors.
It was found that these analogues were able to “protect mice against experimental colitis after oral administration”
The full study can be found by clicking here.